Introduced

Passed House

Passed Senate

Became law

Adjourned sine die. The bill was pending when the session ended, so it did not pass.

Last action · February 12, 2025

To Banking & Insurance (H)

Introduced February 7, 2025

House

Adjourned Sine Die

2025 Regular Session

HB413

AN ACT relating to prescription drugs.

Amend KRS 304.17A-164 to establish cost-sharing requirements for prescription drugs; require rebates to be passed through; establish confidentiality requirements for the rebate information; create a new section of KRS 365.880 to 365.900 to provide that the actual amount of rebates received is a trade secret; provide that compliance with prescription drug cost-sharing and rebate requirements shall not be in violation of the Uniform Trade Secrets Act; amend KRS 304.17C-125, 304.38A-115, 18A.225, and 164.2871 to apply…

Health Benefit Plan Mandate Drugs and Medicines Local Mandate State Employee Health Plan Mandate Education, Higher Effective Dates, Delayed Insurance, Health Pharmacists State Agencies State Employees Actuarial Analysis

Read the full text Kentucky Legislature LegiScan

AI-generated. Always verify with primary sources

Plain-language summary

Beta

This bill sets new rules for how health insurance plans handle prescription drug costs and rebates. It would require that discounts drug manufacturers pay to insurance middlemen (called rebates) be passed along to lower what patients pay out of pocket for their medications. These rules would apply to most Kentucky health plans, including coverage for state employees and college and university employees, starting January 1, 2026. Who it may affect: Kentuckians with health insurance who take prescription drugs, state government employees, and employees of public colleges and universities.

Open official bill text (PDF)·Report a problem with the summary